Systemic amyloidosis with Crohn's disease treated with infliximab

Inflammatory Bowel Diseases

Volumn 14, Issue 3, 2008, Pages 431-432

  Yoon, Kyung Park ^a   Dong, Soo Han ^a   Chang, Soo Eun ^a  

^a Hanyang University Guri Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INFLIXIMAB; MESALAZINE; METRONIDAZOLE; PREDNISOLONE; THYROID HORMONE;

ADULT; AMYLOIDOSIS; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COLON BIOPSY; COLONOSCOPY; CROHN DISEASE; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LABORATORY TEST; LETTER; LOW DRUG DOSE; MALE; NEPHROTIC SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THYROID WEIGHT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AMYLOIDOSIS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 41149124486     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20289     Document Type: Letter

References (7)

1. Efstratiadis G, Mainas A, Leontsini M. Renal amyloidosis complicating Crohn's disease. Case report and review of the literature. J Clin Gastroenterol. 1996;22:308-310.
2. Lovat LB, Madhoo S, Pepys MB, et al. Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease. Gastroenterology. 1997;112:1362-1365.
3. Fernández-Nebro A, Tomero E, Ortiz-Santamaría V, et al. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists. Am J Med. 2005;118: 552-556.
4. Anelli MG, Torres DD, Manno C, et al. Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab. Arthritis Rheum. 2005;52:2519-2520.
5. Bosca MM, Perez-Baylach CM, Solis MA, et al. Secondary amyloidosis in Crohn's disease: treatment with tumour necrosis factor inhibitor. Gut. 2006;55:294-295.
6. Iizuka M, Konno S, Horie Y, et al. Infliximab as a treatment for systemic amyloidosis associated with Crohn's disease. Gut. 2006;55: 744-745.
7. Verschueren P, Lensen F, Lerut E, et al. Benefit of anti-TNFalpha treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis. Ann Rheum Dis. 2003;62: 368-369.